Strs Ohio increased its stake in shares of National Research Co. (NASDAQ:NRCIA) by 12.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,400 shares of the business services provider’s stock after buying an additional 2,300 shares during the quarter. Strs Ohio’s holdings in National Research were worth $760,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Citigroup Inc. boosted its holdings in National Research by 120.2% in the 2nd quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock valued at $224,000 after purchasing an additional 4,531 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in National Research by 252.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,090 shares of the business services provider’s stock valued at $244,000 after purchasing an additional 6,508 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in National Research by 75.2% in the 3rd quarter. Wells Fargo & Company MN now owns 9,450 shares of the business services provider’s stock valued at $356,000 after purchasing an additional 4,056 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in National Research by 5.1% in the 2nd quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock valued at $333,000 after purchasing an additional 600 shares in the last quarter. Finally, Macquarie Group Ltd. purchased a new stake in National Research in the 3rd quarter valued at approximately $488,000. 25.19% of the stock is currently owned by hedge funds and other institutional investors.
In other National Research news, CEO Michael D. Hays sold 1,602,399 shares of National Research stock in a transaction that occurred on Thursday, January 25th. The stock was sold at an average price of $39.03, for a total value of $62,541,632.97. Following the sale, the chief executive officer now owns 5,261,410 shares of the company’s stock, valued at approximately $205,352,832.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 37.54% of the stock is currently owned by insiders.
National Research (NASDAQ:NRCIA) last announced its quarterly earnings data on Tuesday, November 7th. The business services provider reported $0.09 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.21 by ($0.12). National Research had a net margin of 19.09% and a return on equity of 30.84%. analysts predict that National Research Co. will post 0.88 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 12th. Shareholders of record on Friday, December 29th were issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date was Thursday, December 28th. National Research’s dividend payout ratio is presently 80.00%.
A number of equities research analysts have weighed in on NRCIA shares. Zacks Investment Research lowered National Research from a “hold” rating to a “strong sell” rating in a report on Friday, November 10th. BidaskClub lowered National Research from a “buy” rating to a “hold” rating in a report on Friday, January 19th.
National Research Company Profile
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.
Want to see what other hedge funds are holding NRCIA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRCIA).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.